🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

REGISTER NOW 📆 C-Path's Predictive Safety Testing Consortium is delighted to announce its second public workshop on evidentiary considerations for regulatory assessment and qualification of complex in vitro models - CIVMs. i.mtr.cool/vegwolzwbw

ON DEMAND NOW from the RDCA-DAP team, "Hidden in Plain Sight: Autosomal Dominant Tubulointerstitial Kidney Disease." 🔗i.mtr.cool/iryefmoues #CPath #raredisease #RDCADAP #kidneydisease #datasharing

It’s #PKDAwarenessDay and a great time to thank C-Path’s PKD Outcomes Consortium members and its co-directors Ronald Perrone, Frank Czerwiec, and the PKD Foundation’s Susan Bushnell. lnkd.in/gnPtErSg #CPath #PKD #kidneydisease #raredisease #drugdevelopment

Interested in #CPath updates? Be sure to subscribe at i.mtr.cool/wvwxaegoaz For 20 years, C-Path has been providing vital infrastructure to generate a neutral environment for everyone working in drug development to collaborate, not compete. Let's improve lives, together.

Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: i.mtr.cool/ucttvrdifw

On Demand Now!  #CPath's TRxA BioBRIDGe Awards WEBINAR. Content includes an overview of the types of projects TRxA funds, eligibility criteria for BioBRIDGe awards, and details about how to apply. Watch here: i.mtr.cool/kdlbfyxdvr

WATCH NOW  The Use and Development of DHTs with Patient Advocacy  An overview of Actimyo and relevant learnings from use cases across rare disorders spanning different degrees of complexity and readiness.  i.mtr.cool/hnrrfzcfku

ON DEMAND NOW "Mitochondrial and Inherited Metabolic Diseases Task Force: The Influential Role of Patient Advocacy Groups in Registry Data Efforts" webinar w/ CureMITO and The Champ Foundation. View, now: i.mtr.cool/gdpllmekpk #CPath

C-Path’s International Neonatal Consortium and NANN are thrilled to announce the launch of FREE Neonatal #DrugDevelopment Modules for #NICU nurses and neonatal healthcare professionals. Earn CE hours! i.mtr.cool/zivvfageth #CPath #drugdevelopment #regulatoryscience

How Individuals and Organizations Can Support TRxA? Watch! i.mtr.cool/sndhhjrsyu  #CPath's TRxA, is an accelerator focused on supporting academic scientists in advancing novel therapeutics from university labs to drug development pipelines.

REGISTER NOW 📆 C-Path's Predictive Safety Testing Consortium is delighted to announce its second public workshop on evidentiary considerations for regulatory assessment and qualification of complex in vitro models - CIVMs. i.mtr.cool/mkjlxmznqe

ON DEMAND NOW from the RDCA-DAP team, "Hidden in Plain Sight: Autosomal Dominant Tubulointerstitial Kidney Disease." 🔗i.mtr.cool/ycoffpkdrv #CPath #raredisease #RDCADAP #kidneydisease #datasharing

Interested in #CPath updates? Be sure to subscribe at i.mtr.cool/ejpkssxybp For 20 years, C-Path has been providing vital infrastructure to generate a neutral environment for everyone working in drug development to collaborate, not compete. Let's improve lives, together.

Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: i.mtr.cool/lnhdsshqnz

C-Path’s International Neonatal Consortium and NANN are thrilled to announce the launch of FREE Neonatal #DrugDevelopment Modules for #NICU nurses and neonatal healthcare professionals. Earn CE hours! i.mtr.cool/pgtddnrddz #CPath #drugdevelopment #regulatoryscience

How Individuals and Organizations Can Support TRxA? Watch! i.mtr.cool/mnrwhyneos  #CPath's TRxA, is an accelerator focused on supporting academic scientists in advancing novel therapeutics from university labs to drug development pipelines.

REGISTER NOW 📆 C-Path's Predictive Safety Testing Consortium is delighted to announce its second public workshop on evidentiary considerations for regulatory assessment and qualification of complex in vitro models - CIVMs. i.mtr.cool/lzvebjfnti

ON DEMAND NOW from the RDCA-DAP team, "Hidden in Plain Sight: Autosomal Dominant Tubulointerstitial Kidney Disease." 🔗i.mtr.cool/cilippzmqf #CPath #raredisease #RDCADAP #kidneydisease #datasharing

Interested in #CPath updates? Be sure to subscribe at i.mtr.cool/iobopkxoyd For 20 years, C-Path has been providing vital infrastructure to generate a neutral environment for everyone working in drug development to collaborate, not compete. Let's improve lives, together.

Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: i.mtr.cool/ldlphregny